|
Index of reports
> Cases with Hypokalaemia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include hypokalaemia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-02
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Treanda
Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
Indication: Multiple Myeloma
Lenalidomide
Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-07-28
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 75 or 100mg/m2
Indication: Multiple Myeloma
Revlimid
Dosage: 5 or 10mg
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Aspirin
Possible Dexamethasone side effects in
Reported by a physician from Israel on 2012-07-17
Patient:
Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Placebo
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Post Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Cisplatin
Dosage: 46.2 mg/kg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Cytoxan
Dosage: 172 mg, qd
Indication: Chemotherapy
Start date: 2012-06-19
End date: 2012-06-20
Dexamethasone
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.66 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-18
Dexamethasone
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Ondansetron HCL
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded PRE Trial Therapy
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Placebo
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-19
End date: 2012-06-20
Vincristine Sulfate
Dosage: 0.6 mg, qd
Start date: 2012-06-24
End date: 2012-06-24
Etoposide
Dosage: 33 mg, qd
Indication: Chemotherapy
Start date: 2012-06-18
End date: 2012-06-20
Ondansetron
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2012-06-18
End date: 2012-06-22
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Vincristine Sulfate
Dosage: 0.66 mg, qd
Start date: 2012-07-01
End date: 2012-07-01
Blinded Aprepitant
Administration route: Oral
Start date: 2012-06-18
End date: 2012-06-18
Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Resprim; Diamox; Mesna
Possible Dexamethasone side effects in 68 year old female
Reported by a physician from United States on 2012-07-10
Patient: 68 year old female, weighing 80.0 kg (176.0 pounds)
Reactions: Syncope, Hypokalaemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-02
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-02
Cytarabine
Dosage: 4gm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-03
Dexamethasone
Dosage: 40mg every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2012-06-02
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-29
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-28
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: days 1-4
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Japan on 2012-06-27
Patient:
Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: days 1-4
Indication: Multiple Myeloma
Bortezomib
Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
Indication: Multiple Myeloma
Dexamethasone
Dosage: days 1-2, 4-5, 8-9 and 11-12
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-20
Patient: 64 year old male
Reactions: Diarrhoea, Electrolyte Imbalance, Blood Magnesium Decreased, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalidomide
Indication: Multiple Myeloma
Bendamustine Hydrochloride
Dosage: 100 mg/m2;iv 50 mg/m2;iv
Indication: Multiple Myeloma
Start date: 2011-09-28
End date: 2012-05-09
Dexamethasone
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Ondansetron; Cotrim; Fluconazole; Lansoprazole
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-19
Patient: 64 year old male
Reactions: Diarrhoea, Blood Magnesium Decreased, Electrolyte Imbalance, Hypokalaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Thalidomide
Dosage: regimen 1
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Treanda
Dosage: cyclic
Indication: Multiple Myeloma
Start date: 2011-09-28
End date: 2012-05-09
Treanda
Dosage: cyclic, regimen 2
Other drugs received by patient: Acyclovir; Fluconazole; Lansoprazole; Cotrim; Ondansetron
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-06-15
Patient:
Reactions: Anaemia, Multiple Myeloma, Toxicity To Various Agents, Hypokalaemia, Death, Hypophosphataemia, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Thalidomide
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient:
Reactions: Anaemia, Toxicity To Various Agents, Multiple Myeloma, Hypokalaemia, Death, Hypophosphataemia, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Carfilzomib
Dosage: days 8, 9, 15, 16 every 28 days
Indication: Multiple Myeloma
Melphalan Hydrochloride
Indication: Multiple Myeloma
Cisplatin
Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
Indication: Multiple Myeloma
Dexamethasone
Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Steroids NOS
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 1.5 to 3 mg/m^2/day
Indication: Multiple Myeloma
Carfilzomib
Dosage: day 1, 2
Possible Dexamethasone side effects in 78 year old female
Reported by a physician from United States on 2012-05-16
Patient: 78 year old female, weighing 62.9 kg (138.4 pounds)
Reactions: Soft Tissue Infection, Status Epilepticus, Hypertension, Fall, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-15
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-17
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-14
Other drugs received by patient: Aspirin; Zosyn; Cefazolin; Ciprofloxacin
Possible Dexamethasone side effects in 78 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-10
Patient: 78 year old female, weighing 62.6 kg (137.7 pounds)
Reactions: Abscess Soft Tissue, Status Epilepticus, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-07-12
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-10-04
End date: 2011-10-17
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Start date: 2011-10-04
End date: 2011-10-15
Bortezomib
Dosage: 1.3 milligram/sq. meter
Start date: 2011-07-12
Bortezomib
Dosage: 1.3 milligram/sq. meter
Start date: 2011-10-04
End date: 2011-10-14
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-07-12
Other drugs received by patient: Aspirin; Keppra; Atenolol; Aspirin
Possible Dexamethasone side effects in 78 year old female
Reported by a physician from United States on 2012-05-10
Patient: 78 year old female, weighing 62.9 kg (138.4 pounds)
Reactions: Soft Tissue Infection, Status Epilepticus, Fall, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-17
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-14
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-07-12
End date: 2011-10-15
Other drugs received by patient: Aspirin; Zosyn; Cefazolin; Ciprofloxacin
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-04-09
Patient:
Reactions: Hyperkalaemia, Hyperglycaemia, Anaemia, Disease Progression, Hyperuricaemia, Hypokalaemia, Therapeutic Response Decreased, Fatigue, Hypomagnesaemia, Amyloidosis, Neutropenia, Blood Creatinine Increased, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Melphalan Hydrochloride
Dosage: 5 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Revlimid
Dosage: 10 milligram
Administration route: Oral
Other drugs received by patient: Proton Pump Inhibitor; Aspirin
Possible Dexamethasone side effects in 15 year old male
Reported by a consumer/non-health professional from United States on 2012-04-03
Patient: 15 year old male, weighing 110.0 kg (242.0 pounds)
Reactions: Hypersensitivity, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: last dose on 24nov09; 60 mg it:15oct09
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Oncaspar
Dosage: lats dose:05oct2009
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Cyclophosphamide
Dosage: last dose on 27nov09. 2352mg:05oct2009
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Methotrexate
Dosage: last dose on 09nov2009: 24000 mg iv mtx
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Daunorubicin HCL
Dosage: last dose:02oct2009
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Vincristine Sulfate
Dosage: last dose:15oct2009
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Etoposide
Dosage: last dose on 27nov09.
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Asparaginase
Dosage: last dose on 06jan10.
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Dexamethasone
Dosage: last dose:21oct2009
Start date: 2009-04-08
Sprycel
Dosage: last dose on 27dec09. 1820mg:14oct2009
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Hydrocortisone
Dosage: last dose on 24nov2009, 15oct2009
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-04-08
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-03-12
Patient:
Reactions: Confusional State, Abdominal Pain, Pain, Multiple Myeloma, Pelvic Pain, Hypokalaemia, Fatigue, Neuropathy Peripheral, Upper Respiratory Tract Infection, Oedema, Hypocalcaemia, Thrombocytopenia, Cough, Back Pain, Vomiting, Dyspnoea, Cellulitis, Pneumonia, Nausea, Anaemia, Diarrhoea, Neutropenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: as 90 min infusion on day 1 of cycle 1 with other doses given over 30-60 min
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Other drugs received by patient: Aspirin
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07
Patient:
Reactions: Confusional State, Abdominal Pain, Hypersensitivity, Pain, Pulmonary Embolism, Pelvic Pain, Multiple Myeloma, Fall, Hypokalaemia, Thrombophlebitis Septic, Death, Fatigue, Neuropathy Peripheral, Basal Cell Carcinoma, Upper Respiratory Tract Infection, Balance Disorder, Oedema, Hypocalcaemia, Thrombocytopenia, Cough, Back Pain, Dyspnoea, Vomiting, Dysphagia, Cellulitis, Pneumonia, Nausea, Anaemia, Respiratory Distress, Hypophosphataemia, Syncope, Diarrhoea, Neutropenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 3 milligram/sq. meter
Dexamethasone
Dosage: 20 milligram
Revlimid
Dosage: 5 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Indication: Multiple Myeloma
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Bortezomib
Dosage: .7 milligram/sq. meter
Doxorubicin HCL
Dosage: 4 milligram/sq. meter
Indication: Multiple Myeloma
Other drugs received by patient: Heparin; Glucocorticosteroids; Aspirin; Warfarin Sodium
Possible Dexamethasone side effects in
Reported by a physician from Australia on 2012-02-28
Patient:
Reactions: Hyperkalaemia, Pain, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Hypokalaemia, Cerebral Haemorrhage, Fatigue, Neutropenic Infection, Neuropathy Peripheral, Hypocalcaemia, Dizziness, Thrombocytopenia, Blood Creatinine Increased, Vomiting, Atrial Flutter, Hyperglycaemia, Anaemia, Alanine Aminotransferase Increased, Febrile Neutropenia, Hyponatraemia, Intestinal Obstruction, Hypercalcaemia, Diarrhoea, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Istodax
Dosage: 8-14 mg/m2
Indication: Multiple Myeloma
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Other drugs received by patient: Sulfamethoxazole; Trimethoprim; Bisphosphonates; Neupogen; Valaciclovir; Neupogen; Neupogen
Possible Dexamethasone side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-02-02
Patient: male, weighing 57.2 kg (125.8 pounds)
Reactions: Productive Cough, Blood Magnesium Decreased, Hyperuricaemia, Hypokalaemia, Fatigue, Ecchymosis, Oedema, Hypocalcaemia, Blood Creatinine Increased, Decreased Appetite, Dyspnoea, Vomiting, Hyperglycaemia, Hypotension, Haemorrhoids, Febrile Neutropenia, General Physical Health Deterioration, Blood Bicarbonate Decreased, Hepatic Steatosis, Hypophosphataemia, Diarrhoea, Insomnia, Hypothyroidism, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Start date: 2010-11-04
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Start date: 2011-12-22
End date: 2012-01-10
Dexamethasone
Dosage: 12 milligram
Start date: 2011-12-22
End date: 2012-01-10
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-11-04
Other drugs received by patient: Prilosec; Synthroid; Travoprost and Timolol; Potassium Chloride; Acetaminophen; Sodium Chloride; Prochlorperazine; Serax; Levophed; Alendronate Sodium; Ventolin; Atrovent; Xalatan; Solu-Cortef; Timolol Maleate; Pantoprazole Sodium; Potassium Phosphates; Sodium Chloride; Ensure; Inhaler; Senokot; Versed; Pepcid; Mucomyst; Amlodipine; Pravastatin; Heparin; FLU Vaccine; Pravastatin; Colace; Lasix; Alendronate Sodium; Euro-D; Crestor; Normal Saline W / KCL; Gravol TAB; Magnesium Sulfate; Niaspan; Benadryl; Prilosec; Synthroid; Dilaudid; Dilaudid; Calcium; Sodium Chloride; Zovirax; Flexeril; Potassium Chloride; Aspirin; Synthroid; Dilaudid; Calcium Gluconate; Acetaminophen; Anusol; Sodium Chloride; Scopolamine; Euro-D; Lovenox; Sodium Chloride; Heparin; Solu-Cortef; Vitamin D; Hydromorphone HCL; Lasix; Sodium Chloride; Lactulose; Sodium Chloride; Lyrica; Pneumovax 23
Possible Dexamethasone side effects in female
Reported by a physician from United Kingdom on 2012-02-02
Patient: female, weighing 113.6 kg (249.9 pounds)
Reactions: Fatigue, Nausea, Blood Creatinine Increased, Thrombocytopenia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Cytarabine
Dosage: 2mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-25
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-24
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Possible Dexamethasone side effects in 65 year old female
Reported by a physician from United States on 2012-01-03
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: International Normalised Ratio Increased, Acidosis, Renal Failure Chronic, Hypokalaemia, Sepsis, Hypomagnesaemia, Hypocalcaemia, Kidney Infection, Blood Creatinine Increased, Lymphocyte Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-09-30
Cefazolin
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-10-03
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-10-01
Other drugs received by patient: Fluids; Warfarin Sodium; Antibiotics; Electrolyte Replacement; Aspirin
Possible Dexamethasone side effects in 65 year old female
Reported by a physician from United States on 2011-12-29
Patient: 65 year old female, weighing 86.0 kg (189.2 pounds)
Reactions: International Normalised Ratio Increased, Acidosis, Renal Failure Chronic, Hypokalaemia, Hypomagnesaemia, Sepsis, Hypocalcaemia, Kidney Infection, Blood Creatinine Increased, Lymphocyte Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-09-30
Dexamethasone
Dosage: 20 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-10-01
Cefazolin
Indication: Product Used FOR Unknown Indication
Lenalidomide
Dosage: 25 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-20
End date: 2011-10-03
Other drugs received by patient: Aspirin; Warfarin Sodium
Possible Dexamethasone side effects in female
Reported by a physician from United Kingdom on 2011-12-19
Patient: female, weighing 113.6 kg (249.9 pounds)
Reactions: Fatigue, Nausea, Thrombocytopenia, Blood Creatinine Increased, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-24
Cytarabine
Dosage: 2mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-25
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Possible Dexamethasone side effects in female
Reported by a physician from United Kingdom on 2011-12-08
Patient: female, weighing 113.6 kg (249.9 pounds)
Reactions: Fatigue, Nausea, Blood Creatinine Increased, Thrombocytopenia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40mg every 3 weeks
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Cytarabine
Dosage: 2mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-25
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-23
Cisplatin
Dosage: 100mgm2 every 3 weeks
Indication: Diffuse Large B-Cell Lymphoma Recurrent
Start date: 2011-11-24
Page 1 Next >>
|
